CAD 9.1
(-1.3%)
Breakdown | 2023 | 2022 | 2021 |
---|---|---|---|
Operating Cash Flow | 5.49 Million | -6.88 Million | -61.38 Million |
Net Income | 3.33 Million | -10.69 Million | 3.18 Million |
Depreciation & Amortization | - | - | - |
Deferred income taxes | - | - | - |
Stock-based compensation | - | - | - |
Change in working capital | -186.56 Thousand | -7644.00 | 331.43 Thousand |
Other non-cash items | 2.34 Million | 3.82 Million | -64.89 Million |
Investing Cash Flow | - | - | - |
Investments in PPE | - | - | - |
Acquisitions | - | - | - |
Investment purchases | - | - | - |
Sales/Maturities of investments | - | - | - |
Other Investing Activities | - | - | - |
Financing Cash Flow | -5.39 Million | 6.75 Million | 61.75 Million |
Debt repayment | - | - | - |
Dividends payments | -2.72 Million | -2.71 Million | -1.28 Million |
Common Stock Repurchased | -2.66 Million | - | - |
Common Stock Issuance | - | 4.56 Million | 32.21 Million |
Other Financing Activities | - | 4.89 Million | 30.82 Million |
Accounts receivables | -7148.00 | -47.28 Thousand | -126.99 Thousand |
Accounts payables | 25.81 Thousand | 28.37 Thousand | 55.72 Thousand |
Inventory | -23.22 Thousand | - | - |
Other working capital | -181.99 Thousand | 11.26 Thousand | 402.7 Thousand |
Cash at beginning of period | 243.14 Thousand | 370.05 Thousand | - |
Cash at end of period | 339.36 Thousand | 243.14 Thousand | 370.05 Thousand |
Capital Expenditure | - | - | - |
Effect of forex changes on cash | -2141.00 | 4024.00 | -915.00 |
Net cash flow / Change in cash | 96.22 Thousand | -126.91 Thousand | 370.05 Thousand |
Free Cash Flow | 5.49 Million | -6.88 Million | -61.38 Million |
Breakdown | 2023 FY | 2022 FY | 2021 FY |
---|---|---|---|
Operating Cash Flow | - | - | - |
Net Income | 3.33 Million | -10.69 Million | 3.18 Million |
Depreciation & Amortization | - | - | - |
Deferred income taxes | - | - | - |
Stock-based compensation | - | - | - |
Change in working capital | -186.56 Thousand | -7644.00 | 331.43 Thousand |
Other non-cash items | 2.34 Million | 3.82 Million | -64.89 Million |
Investing Cash Flow | - | - | - |
Investments in PPE | - | - | - |
Acquisitions | - | - | - |
Investment purchases | - | - | - |
Sales/Maturities of investments | - | - | - |
Other Investing Activities | - | - | - |
Financing Cash Flow | -5.39 Million | 6.75 Million | 61.75 Million |
Debt repayment | - | - | - |
Dividends payments | -2.72 Million | -2.71 Million | -1.28 Million |
Common Stock Repurchased | -2.66 Million | - | - |
Common Stock Issuance | - | 4.56 Million | 32.21 Million |
Other Financing Activities | - | 4.89 Million | 30.82 Million |
Accounts receivables | -7148.00 | -47.28 Thousand | -126.99 Thousand |
Accounts payables | 25.81 Thousand | 28.37 Thousand | 55.72 Thousand |
Inventory | -23.22 Thousand | - | - |
Other working capital | -181.99 Thousand | 11.26 Thousand | 402.7 Thousand |
Cash at beginning of period | 243.14 Thousand | 370.05 Thousand | - |
Cash at end of period | 339.36 Thousand | 243.14 Thousand | 370.05 Thousand |
Capital Expenditure | - | - | - |
Effect of forex changes on cash | -2141.00 | 4024.00 | -915.00 |
Net cash flow / Change in cash | 96.22 Thousand | -126.91 Thousand | 370.05 Thousand |
Free Cash Flow | 5.49 Million | -6.88 Million | -61.38 Million |
5916
OZYMF
002879
AGL
AGROUP
ODPV3